Company profile for Agtc

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

AGTC is a clinical-stage biotechnology company that uses its proprietary gene therapy platform to develop products designed to transform the lives of patients with severe diseases, with an initial focus in ophthalmology. AGTC's lead product candidates are designed to treat inherited orphan diseases of the eye, caused by mutations in single genes that significantly affect visual function and currently lack effective medical tre...
AGTC is a clinical-stage biotechnology company that uses its proprietary gene therapy platform to develop products designed to transform the lives of patients with severe diseases, with an initial focus in ophthalmology. AGTC's lead product candidates are designed to treat inherited orphan diseases of the eye, caused by mutations in single genes that significantly affect visual function and currently lack effective medical treatments.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
14193 NW 119th Terrace, Suite #10 Alachua, Florida 32615
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/06/18/2900369/0/en/Genetic-Technologies-Expands-Operational-Capacity-in-North-America.html

GLOBENEWSWIRE
18 Jun 2024

https://www.globenewswire.com//news-release/2022/12/01/2565756/30580/en/Syncona-Limited-Portfolio-Company-Successfully-Completes-Tender-Offer-and-Acquisition-of-Applied-Genetic-Technologies-Corporation.html

GLOBENEWSWIRE
01 Dec 2022

https://www.globenewswire.com//news-release/2022/11/29/2563939/30580/en/Syncona-Limited-Portfolio-Company-Extends-Tender-Offer-to-Acquire-Applied-Genetic-Technologies-Corporation.html

GLOBENEWSWIRE
29 Nov 2022

https://www.globenewswire.com//news-release/2022/11/22/2561243/30580/en/REMINDER-AGTC-Urges-Shareholders-to-Tender-Their-Shares-by-November-28-2022-REMINDER.html

GLOBENEWSWIRE
22 Nov 2022

https://www.globenewswire.com/news-release/2022/11/14/2555422/30580/en/Applied-Genetic-Technologies-Corporation-Urges-Shareholders-to-Tender-Their-Shares-by-November-28-2022.html

GLOBENEWSWIRE
14 Nov 2022

https://www.globenewswire.com/news-release/2022/11/03/2547668/30580/en/Applied-Genetic-Technologies-Corporation-Reminds-Shareholders-to-Tender-Their-Shares-by-November-28-2022.html

GLOBENEWSWIRE
03 Nov 2022

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty